Escitalopram reduces hot flflashes in nondepressed menopausal women: A pilot study

Annals of Clinical Psychiatry

Volumn 21, Issue 2, 2009, Pages 70-76

  Dobkin, Roseanne DeFronzo ^a   Menza, Matthew ^a   Allen, Lesley A ^a   Marin, Humberto ^a   Bienfait, Karina L ^a   Tiu, Jade ^a   Howarth, Jennifer ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Escitalopram; Hot flashes; Nonclinical sample; Nondepressed menopausal women

Indexed keywords

EID: 84856034645     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Pearce J, Hawton K, Blake F. Psychological and sexual symptoms associated with the menopause and the effects of hormone replacement therapy. Br J Psychiatry. 1995;167:163-173. (Pubitemid 26194125)
2. Montgomery JC, Studd JW. Psychological and sexual aspects of menopause. Br J Hosp Med. 1991;45: 300-302.
3. Dennerstein L. Well-being, symptoms, and the menopause transition. Maturitas. 1996;23:147-157.
4. Nagamani M, Kelver ME, Smith ER. Treatment of menopausal hot flashes with transdermal administration of clonidine. Am J Obstet Gynecol. 1987;156: 561-565. (Pubitemid 17053020)
5. Berendsen HH. The role of serotonin in hot flushes. Maturitas. 2000;36:155-164.
6. Rossouw JE, Anderson GL, Prentice RL, et al, and the Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333. (Pubitemid 34761611)
7. Vickers MR, MacLennan AH, Lawton B, et al. Main morbidities recorded in the Women's International Study of Long Duration on Oestrogen after Menopause (WISDOM): a randomized controlled trial of hormone replacement therapy in postmenopausal women. BMJ. 2007;335:239.
8. Rodriguez C, Patel AV, Calle EE, et al. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. JAMA. 2001;285:1460-1465. (Pubitemid 32221894)
9. Shumaker SA, Legault C, Rapp SR, et al, and the WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289:2651-2662. (Pubitemid 37430136)
10. Fletcher SW, Colditz GA. Failure of estrogen plus progestin therapy for prevention. JAMA. 2002;288: 366-368. (Pubitemid 34761617)
11. Nelson HD, Humphrey LL, Nygren P, et al. Postmenopausal hormone replacement therapy: scientific review. JAMA. 2002;288:872-881.
12. Boraz MA, Simkin-Silverman LR, Wing RR, et al. Hormone replacement therapy use and menopausal symptoms among women participating in a behavioral lifestyle intervention. Prev Med. 2001;33(2 pt 1):108-114. (Pubitemid 32744638)
13. Young RL, Kumar NS, Goldzieher JW. Management of menopause when estrogen cannot be used. Drugs. 1990;40:220-230.
14. Grady D, Gebretsadik T, Kerlikowske K, et al. Hormone replacement therapy and endometrial cancer risk: meta-analysis. Obstet Gynecol. 1995;85:304-313.
15. Connelly MT, Richardson M, Platt R. Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995. J Gen Intern Med. 2000;15:542-550.
16. Hill DA, Weiss NS, LaCroix AZ. Adherence to postmenopausal hormone therapy during the year after the initial prescription: A population based study. Am J Obstet Gynecol. 2000;182:270-276. (Pubitemid 30127334)
17. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary artery disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study Research Group. JAMA. 1998;280:605-613. (Pubitemid 28502636)
18. Nerhood RC. Making a decision about ERT/HRT. Evidence to consider in initiating and continuing protective therapy. Postgrad Med. 2001;109:167-170, 173-174, 178.
19. Philp HA. Hot flashes - a review of the literature on alternative and complementary treatment approaches. Altern Med Review. 2003;8:284-302. (Pubitemid 37099888)
20. Kessel B, Kronenberg F. The role of complementary and alternative medicine in the management of menopausal symptoms. Endocrinol Metab Clin North Am. 2004;33:717-739. (Pubitemid 39402978)
21. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med. 2002;137:805-813. (Pubitemid 35334452)
22. Nedrow A, Miller J, Walker M, et al. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med. 2006;166:1453-1465. (Pubitemid 44125864)
23. Grady D. Clinical practice. Management of menopausal symptoms. N Engl J Med. 2006;355:2338-2347. (Pubitemid 44837782)
24. Nelson HD, Vesco KK, Haney E, et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA. 2006;295:2057-2071. (Pubitemid 44794007)
25. Loprinzi CL, Pisansky TM, Fonseca R, et al. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol. 1998;16:2377-2381. (Pubitemid 28309031)
26. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomized controlled trial. Lancet. 2000;356:2059-2065.
27. Stearns V, Isaacs C, Rowland J, et al. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann Oncol. 2000;11:17-22. (Pubitemid 30084574)
28. Waldinger MD, Berendsen HH, Schweitzer DH. Treatment of hot flushes with mirtazapine: four case reports. Maturitas. 2000;36:165-168.
29. Loprinzi CL, Sloan JA, Perez EA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol. 2002;20:1578-1583. (Pubitemid 34260538)
30. Oishi A, Mochizuki Y, Otsu R, et al. Pilot study of fluvoxamine treatment for climacteric symptoms in Japanese women. Biopsychosoc Med. 2007;1:12.
31. Weitzner MA, Moncello J, Jacobsen PB, et al. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J Pain Symptom Manage. 2002;23:337-345. (Pubitemid 34462946)
32. Stearns V, Beebe KL, Iyengar M, et al. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA. 2003;289:2827-2834. (Pubitemid 37430118)
33. Stearns V, Slack R, Greep N, et al. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol. 2005;23:6919-6930.
34. Suvanto-Luukkonen E, Koivunen R, Sundström H, et al. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause. 2005;12:18-26. (Pubitemid 40204889)
35. Grady D, Cohen B, Tice J, et al. Ineffectiveness of sertraline for treatment of menopausal hot flashes: a randomized controlled trial. Obstet Gynecol. 2007;109: 823-830. (Pubitemid 46559068)
36. SperoffL, Gass M, Constantine G, et al, and the Study 315 Investigators. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial. Obstet Gynecol. 2008;111:77-87.
37. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Association; 1994.
38. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders (SCIDI). Washington, DC: American Psychiatric Publishing, Inc.; 1997.
39. Hamilton M. Hamilton depression scale. In: Guy W, ed. ECDEU Assessment manual for psychopharmacology. Rev ed. Washington, DC: US Department of Health, Education, and Welfare; 1976.
40. Buysse DJ, Reynolds CF 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193-213. (Pubitemid 19144991)
41. Sloan JA, Loprinzi CL, Novotny PJ, et al. Methodologic lessons learned from hot flash studies. J Clin Oncol. 2001;19:4280-4290. (Pubitemid 33096775)
42. Hamilton M. Hamilton anxiety scale. In: Guy W, ed. ECDEU Assessment manual for psychopharmacology. Rev ed. Washington, DC: US Department of Health, Education, and Welfare; 1976:193-198.
43. Hilditch JR, Lewis J, Peter A, et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas. 1996;24:161-175.
44. Greene JG. Constructing a standard climacteric scale. Maturitas. 1998;29:25-31. (Pubitemid 28247565)
45. Montgomery SA, Kasper S. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Int Clin Psychopharmacol. 1995;9(suppl 4):33-40.
46. Waugh J, Goa KL. Escitalopram: a review of its use in the management of major depressive and anxiety disorders. CNS Drugs. 2003;17:343-362. (Pubitemid 36469972)
47. Burke WJ, Gergel I, Bose A. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry. 2002;63:331-336. (Pubitemid 34456361)
48. Wade A, Michael Lemming O, Bang Hedegaard K. Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol. 2002;17:95-102. (Pubitemid 34442189)
49. Albertazzi P. Noradrenergic and serotonergic modulation to treat vasomotor symptoms. J Br Menopause Soc. 2006;12:7-11. (Pubitemid 43349416)
50. Soares CN, Arsenio H, Joffe H, et al. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep and quality of life. Menopause. 2006;13:780-786. (Pubitemid 44435032)
51. Secreto G, Chiechi LM, Amadori A, et al. Soy isoflavones and melatonin for the relief of climacteric symptoms: a multicenter, double-blind randomized study. Maturitas. 2004;47:11-20. (Pubitemid 38050011)
52. Simon JA, Stevens RE, Ayres SA, et al. Perimenopausal women in estrogen vasomotor trials: contribution to placebo effect and efficacy outcome. Climacteric. 2001;4:19-27. (Pubitemid 32448484)
53. Cumming GP, Herald J, Moncur R, et al. Women's attitudes to hormone replacement therapy, alternative therapy and sexual health: a web-based survey. Menopause Int. 2007;13:79-83.
54. Farrell E. Medical choices available for management of menopause. Best Pract Res Clin Endocrinol Metab. 2003;17:1-16.
55. Reynolds RF, Obermeyer CM, Walker AM, et al. The role of treatment intentions and concerns about side effects in women's decision to discontinue postmenopausal hormone therapy. Maturitas. 2002;43:183-194. (Pubitemid 35346548)